nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—clitoris—polycystic ovary syndrome	0.143	0.406	CbGeAlD
Pentoxifylline—Emotional distress—Metformin—polycystic ovary syndrome	0.0185	0.0858	CcSEcCtD
Pentoxifylline—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0166	0.0766	CcSEcCtD
Pentoxifylline—NT5E—embryo—polycystic ovary syndrome	0.0135	0.0382	CbGeAlD
Pentoxifylline—CYP1A2—urine—polycystic ovary syndrome	0.0116	0.033	CbGeAlD
Pentoxifylline—Heartburn—Metformin—polycystic ovary syndrome	0.0115	0.053	CcSEcCtD
Pentoxifylline—NT5E—endometrium—polycystic ovary syndrome	0.00986	0.0279	CbGeAlD
Pentoxifylline—NT5E—uterus—polycystic ovary syndrome	0.00908	0.0257	CbGeAlD
Pentoxifylline—NT5E—pituitary gland—polycystic ovary syndrome	0.00892	0.0253	CbGeAlD
Pentoxifylline—NT5E—adipose tissue—polycystic ovary syndrome	0.00888	0.0252	CbGeAlD
Pentoxifylline—NT5E—adrenal gland—polycystic ovary syndrome	0.00797	0.0226	CbGeAlD
Pentoxifylline—ADORA2B—pituitary gland—polycystic ovary syndrome	0.00764	0.0216	CbGeAlD
Pentoxifylline—ADORA2B—adipose tissue—polycystic ovary syndrome	0.00761	0.0215	CbGeAlD
Pentoxifylline—NT5E—female gonad—polycystic ovary syndrome	0.00743	0.021	CbGeAlD
Pentoxifylline—NT5E—vagina—polycystic ovary syndrome	0.00738	0.0209	CbGeAlD
Pentoxifylline—Lightheadedness—Metformin—polycystic ovary syndrome	0.00705	0.0326	CcSEcCtD
Pentoxifylline—NT5E—endocrine gland—polycystic ovary syndrome	0.00691	0.0196	CbGeAlD
Pentoxifylline—PDE4A—adipose tissue—polycystic ovary syndrome	0.00678	0.0192	CbGeAlD
Pentoxifylline—Ear pain—Metformin—polycystic ovary syndrome	0.00671	0.031	CcSEcCtD
Pentoxifylline—ADORA2B—vagina—polycystic ovary syndrome	0.00632	0.0179	CbGeAlD
Pentoxifylline—Nasal congestion—Metformin—polycystic ovary syndrome	0.00628	0.0291	CcSEcCtD
Pentoxifylline—PDE4A—adrenal gland—polycystic ovary syndrome	0.00608	0.0172	CbGeAlD
Pentoxifylline—PDE5A—adipose tissue—polycystic ovary syndrome	0.00576	0.0163	CbGeAlD
Pentoxifylline—ADORA2A—adrenal gland—polycystic ovary syndrome	0.00568	0.0161	CbGeAlD
Pentoxifylline—PDE4A—female gonad—polycystic ovary syndrome	0.00567	0.0161	CbGeAlD
Pentoxifylline—ADORA1—adipose tissue—polycystic ovary syndrome	0.00546	0.0155	CbGeAlD
Pentoxifylline—PDE5A—adrenal gland—polycystic ovary syndrome	0.00517	0.0146	CbGeAlD
Pentoxifylline—Abdominal distension—Metformin—polycystic ovary syndrome	0.00498	0.023	CcSEcCtD
Pentoxifylline—ADORA2A—endocrine gland—polycystic ovary syndrome	0.00492	0.0139	CbGeAlD
Pentoxifylline—PDE5A—female gonad—polycystic ovary syndrome	0.00482	0.0137	CbGeAlD
Pentoxifylline—Angina pectoris—Metformin—polycystic ovary syndrome	0.00482	0.0223	CcSEcCtD
Pentoxifylline—PDE5A—vagina—polycystic ovary syndrome	0.00479	0.0136	CbGeAlD
Pentoxifylline—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00474	0.0219	CcSEcCtD
Pentoxifylline—ADORA1—vagina—polycystic ovary syndrome	0.00454	0.0129	CbGeAlD
Pentoxifylline—PDE4B—endometrium—polycystic ovary syndrome	0.00449	0.0127	CbGeAlD
Pentoxifylline—PDE5A—endocrine gland—polycystic ovary syndrome	0.00448	0.0127	CbGeAlD
Pentoxifylline—Infestation NOS—Metformin—polycystic ovary syndrome	0.00441	0.0204	CcSEcCtD
Pentoxifylline—Infestation—Metformin—polycystic ovary syndrome	0.00441	0.0204	CcSEcCtD
Pentoxifylline—Drowsiness—Metformin—polycystic ovary syndrome	0.00441	0.0204	CcSEcCtD
Pentoxifylline—ADORA1—endocrine gland—polycystic ovary syndrome	0.00425	0.012	CbGeAlD
Pentoxifylline—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00417	0.0193	CcSEcCtD
Pentoxifylline—PDE4B—pituitary gland—polycystic ovary syndrome	0.00406	0.0115	CbGeAlD
Pentoxifylline—PDE4B—adipose tissue—polycystic ovary syndrome	0.00404	0.0115	CbGeAlD
Pentoxifylline—Hepatitis—Metformin—polycystic ovary syndrome	0.00396	0.0183	CcSEcCtD
Pentoxifylline—Flushing—Metformin—polycystic ovary syndrome	0.00367	0.017	CcSEcCtD
Pentoxifylline—PDE4B—adrenal gland—polycystic ovary syndrome	0.00363	0.0103	CbGeAlD
Pentoxifylline—Immune system disorder—Metformin—polycystic ovary syndrome	0.00358	0.0165	CcSEcCtD
Pentoxifylline—Erythema—Metformin—polycystic ovary syndrome	0.00345	0.0159	CcSEcCtD
Pentoxifylline—Flatulence—Metformin—polycystic ovary syndrome	0.0034	0.0157	CcSEcCtD
Pentoxifylline—PDE4B—female gonad—polycystic ovary syndrome	0.00338	0.00958	CbGeAlD
Pentoxifylline—Dysgeusia—Metformin—polycystic ovary syndrome	0.00337	0.0156	CcSEcCtD
Pentoxifylline—PDE4B—vagina—polycystic ovary syndrome	0.00336	0.00952	CbGeAlD
Pentoxifylline—Muscle spasms—Metformin—polycystic ovary syndrome	0.00331	0.0153	CcSEcCtD
Pentoxifylline—Vision blurred—Metformin—polycystic ovary syndrome	0.00325	0.015	CcSEcCtD
Pentoxifylline—Tremor—Metformin—polycystic ovary syndrome	0.00323	0.0149	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0032	0.0148	CcSEcCtD
Pentoxifylline—PDE4B—endocrine gland—polycystic ovary syndrome	0.00314	0.00891	CbGeAlD
Pentoxifylline—Malaise—Metformin—polycystic ovary syndrome	0.00311	0.0144	CcSEcCtD
Pentoxifylline—Palpitations—Metformin—polycystic ovary syndrome	0.00305	0.0141	CcSEcCtD
Pentoxifylline—Hypertension—Metformin—polycystic ovary syndrome	0.00298	0.0138	CcSEcCtD
Pentoxifylline—Chest pain—Metformin—polycystic ovary syndrome	0.00293	0.0136	CcSEcCtD
Pentoxifylline—Myalgia—Metformin—polycystic ovary syndrome	0.00293	0.0136	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00291	0.0135	CcSEcCtD
Pentoxifylline—Discomfort—Metformin—polycystic ovary syndrome	0.0029	0.0134	CcSEcCtD
Pentoxifylline—Oedema—Metformin—polycystic ovary syndrome	0.00281	0.013	CcSEcCtD
Pentoxifylline—Infection—Metformin—polycystic ovary syndrome	0.00279	0.0129	CcSEcCtD
Pentoxifylline—Shock—Metformin—polycystic ovary syndrome	0.00277	0.0128	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00275	0.0127	CcSEcCtD
Pentoxifylline—Skin disorder—Metformin—polycystic ovary syndrome	0.00273	0.0126	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00272	0.0126	CcSEcCtD
Pentoxifylline—Anorexia—Metformin—polycystic ovary syndrome	0.00268	0.0124	CcSEcCtD
Pentoxifylline—Hypotension—Metformin—polycystic ovary syndrome	0.00263	0.0122	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00256	0.0119	CcSEcCtD
Pentoxifylline—Dyspnoea—Metformin—polycystic ovary syndrome	0.00251	0.0116	CcSEcCtD
Pentoxifylline—Somnolence—Metformin—polycystic ovary syndrome	0.0025	0.0116	CcSEcCtD
Pentoxifylline—Dyspepsia—Metformin—polycystic ovary syndrome	0.00248	0.0115	CcSEcCtD
Pentoxifylline—Decreased appetite—Metformin—polycystic ovary syndrome	0.00244	0.0113	CcSEcCtD
Pentoxifylline—Constipation—Metformin—polycystic ovary syndrome	0.00241	0.0111	CcSEcCtD
Pentoxifylline—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00232	0.0107	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0023	0.0106	CcSEcCtD
Pentoxifylline—Urticaria—Metformin—polycystic ovary syndrome	0.00223	0.0103	CcSEcCtD
Pentoxifylline—Abdominal pain—Metformin—polycystic ovary syndrome	0.00222	0.0103	CcSEcCtD
Pentoxifylline—Asthenia—Metformin—polycystic ovary syndrome	0.00202	0.00933	CcSEcCtD
Pentoxifylline—Pruritus—Metformin—polycystic ovary syndrome	0.00199	0.0092	CcSEcCtD
Pentoxifylline—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00193	0.00547	CbGeAlD
Pentoxifylline—Diarrhoea—Metformin—polycystic ovary syndrome	0.00192	0.0089	CcSEcCtD
Pentoxifylline—Dizziness—Metformin—polycystic ovary syndrome	0.00186	0.0086	CcSEcCtD
Pentoxifylline—Vomiting—Metformin—polycystic ovary syndrome	0.00179	0.00827	CcSEcCtD
Pentoxifylline—Rash—Metformin—polycystic ovary syndrome	0.00177	0.0082	CcSEcCtD
Pentoxifylline—Dermatitis—Metformin—polycystic ovary syndrome	0.00177	0.0082	CcSEcCtD
Pentoxifylline—Headache—Metformin—polycystic ovary syndrome	0.00176	0.00815	CcSEcCtD
Pentoxifylline—Nausea—Metformin—polycystic ovary syndrome	0.00167	0.00773	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000161	0.000373	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00016	0.000372	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—INS—polycystic ovary syndrome	0.00016	0.000372	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00016	0.000372	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000159	0.00037	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000159	0.00037	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000159	0.000369	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000159	0.000368	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000158	0.000367	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000157	0.000365	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000157	0.000365	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000157	0.000364	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000156	0.000361	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000156	0.000361	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000155	0.00036	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000153	0.000356	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000152	0.000353	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000151	0.00035	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00015	0.000348	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000149	0.000346	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000148	0.000344	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000148	0.000343	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000148	0.000342	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000147	0.000342	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000147	0.00034	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000146	0.000339	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000146	0.000338	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000146	0.000338	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000146	0.000338	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000145	0.000335	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000144	0.000334	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000143	0.000333	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000143	0.000331	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000142	0.000329	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000142	0.000329	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000139	0.000324	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000139	0.000323	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000138	0.000321	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000138	0.00032	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000137	0.000317	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000136	0.000316	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000135	0.000313	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000134	0.000312	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000134	0.00031	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000133	0.000308	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000132	0.000307	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000132	0.000307	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000132	0.000306	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000132	0.000306	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000131	0.000304	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INSR—polycystic ovary syndrome	0.00013	0.000302	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00013	0.000302	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000129	0.000299	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000129	0.000299	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000128	0.000298	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000127	0.000295	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000126	0.000293	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000126	0.000292	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000124	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000124	0.000288	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000124	0.000287	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000123	0.000285	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000123	0.000285	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000122	0.000284	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000122	0.000284	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000122	0.000283	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000121	0.000282	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000121	0.00028	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00012	0.00028	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.00012	0.000279	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.00012	0.000278	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.00012	0.000278	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000119	0.000277	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	0.000118	0.000273	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000117	0.000272	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000117	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000116	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000115	0.000268	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000115	0.000268	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000115	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000115	0.000267	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000115	0.000267	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000114	0.000265	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000114	0.000265	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000113	0.000261	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000112	0.00026	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000112	0.00026	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000111	0.000259	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000111	0.000257	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000111	0.000257	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000111	0.000257	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000111	0.000257	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000109	0.000253	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000108	0.000251	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000107	0.000249	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000107	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000107	0.000248	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000107	0.000248	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000106	0.000245	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000105	0.000245	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000105	0.000244	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000105	0.000243	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000105	0.000243	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000104	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000104	0.000241	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000103	0.000239	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000103	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000102	0.000238	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000101	0.000235	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000101	0.000234	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000101	0.000234	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.92e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.88e-05	0.000229	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—polycystic ovary syndrome	9.81e-05	0.000228	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRL—polycystic ovary syndrome	9.79e-05	0.000227	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	9.78e-05	0.000227	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGFR—polycystic ovary syndrome	9.76e-05	0.000226	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—polycystic ovary syndrome	9.7e-05	0.000225	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRL—polycystic ovary syndrome	9.67e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.65e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	9.56e-05	0.000222	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	9.56e-05	0.000222	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.47e-05	0.00022	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.43e-05	0.000219	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.41e-05	0.000218	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	9.37e-05	0.000218	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	9.37e-05	0.000218	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.32e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PGR—polycystic ovary syndrome	9.32e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.28e-05	0.000216	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	9.25e-05	0.000215	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GNAS—polycystic ovary syndrome	9.19e-05	0.000213	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.17e-05	0.000213	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—IL6—polycystic ovary syndrome	9.06e-05	0.00021	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.76e-05	0.000203	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	8.71e-05	0.000202	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	8.69e-05	0.000202	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	8.66e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	8.66e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.61e-05	0.0002	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRG1—polycystic ovary syndrome	8.6e-05	0.0002	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	8.52e-05	0.000198	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GNAS—polycystic ovary syndrome	8.51e-05	0.000197	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	8.34e-05	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	8.26e-05	0.000192	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.2e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.11e-05	0.000188	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.1e-05	0.000188	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	8.06e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRG1—polycystic ovary syndrome	8.05e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	8.02e-05	0.000186	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRG1—polycystic ovary syndrome	7.95e-05	0.000185	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	7.95e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—LEP—polycystic ovary syndrome	7.94e-05	0.000184	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	7.62e-05	0.000177	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	7.58e-05	0.000176	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRL—polycystic ovary syndrome	7.56e-05	0.000175	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	7.54e-05	0.000175	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	7.41e-05	0.000172	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	7.41e-05	0.000172	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS2—polycystic ovary syndrome	7.36e-05	0.000171	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	7.28e-05	0.000169	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—LEP—polycystic ovary syndrome	7.21e-05	0.000167	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	7.17e-05	0.000166	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	7.12e-05	0.000165	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.08e-05	0.000164	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	7.01e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.9e-05	0.00016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—polycystic ovary syndrome	6.82e-05	0.000158	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS2—polycystic ovary syndrome	6.81e-05	0.000158	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—INS—polycystic ovary syndrome	6.78e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—LEP—polycystic ovary syndrome	6.75e-05	0.000157	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—LEP—polycystic ovary syndrome	6.67e-05	0.000155	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	6.65e-05	0.000154	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.56e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.55e-05	0.000152	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IRS1—polycystic ovary syndrome	6.43e-05	0.000149	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.33e-05	0.000147	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.23e-05	0.000145	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	6.22e-05	0.000144	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	6.21e-05	0.000144	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—polycystic ovary syndrome	6.19e-05	0.000144	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—INS—polycystic ovary syndrome	6.16e-05	0.000143	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.02e-05	0.00014	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.95e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT2—polycystic ovary syndrome	5.95e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IRS1—polycystic ovary syndrome	5.95e-05	0.000138	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	5.89e-05	0.000137	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—polycystic ovary syndrome	5.8e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—INS—polycystic ovary syndrome	5.76e-05	0.000134	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—polycystic ovary syndrome	5.73e-05	0.000133	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—INS—polycystic ovary syndrome	5.7e-05	0.000132	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.65e-05	0.000131	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	5.62e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.58e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.57e-05	0.000129	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	5.55e-05	0.000129	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IGF1—polycystic ovary syndrome	5.51e-05	0.000128	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT2—polycystic ovary syndrome	5.51e-05	0.000128	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	5.32e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.3e-05	0.000123	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.23e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—LEP—polycystic ovary syndrome	5.21e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.01e-05	0.000116	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	5e-05	0.000116	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	4.77e-05	0.000111	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.72e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	4.65e-05	0.000108	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—IL6—polycystic ovary syndrome	4.55e-05	0.000106	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—polycystic ovary syndrome	4.48e-05	0.000104	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.47e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—INS—polycystic ovary syndrome	4.45e-05	0.000103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	4.35e-05	0.000101	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	4.31e-05	9.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	4.3e-05	9.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.28e-05	9.94e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.26e-05	9.9e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.26e-05	9.88e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.21e-05	9.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.12e-05	9.57e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.09e-05	9.49e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.89e-05	9.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	3.79e-05	8.8e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	3.67e-05	8.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.64e-05	8.45e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.6e-05	8.35e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	3.54e-05	8.22e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	3.4e-05	7.9e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.38e-05	7.85e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.36e-05	7.8e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.34e-05	7.74e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.29e-05	7.64e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.17e-05	7.36e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.12e-05	7.25e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6—polycystic ovary syndrome	2.96e-05	6.88e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.81e-05	6.53e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.7e-05	6.27e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6—polycystic ovary syndrome	2.69e-05	6.24e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.63e-05	6.1e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6—polycystic ovary syndrome	2.52e-05	5.85e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6—polycystic ovary syndrome	2.49e-05	5.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.47e-05	5.74e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.21e-05	5.12e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.1e-05	4.88e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	1.99e-05	4.62e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6—polycystic ovary syndrome	1.94e-05	4.51e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.86e-05	4.31e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.51e-05	3.5e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.49e-05	3.45e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.48e-05	3.43e-05	CbGpPWpGaD
